Leichtner AM - Search Results

1

Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.

El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP. El-Hallak M, et al. Among authors: leichtner am. J Pediatr. 2007 Apr;150(4):376-82. doi: 10.1016/j.jpeds.2006.10.067. J Pediatr. 2007. PMID: 17382113

2

Oral tacrolimus treatment of severe colitis in children.

Bousvaros A, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM. Bousvaros A, et al. Among authors: leichtner am. J Pediatr. 2000 Dec;137(6):794-9. doi: 10.1067/mpd.2000.109193. J Pediatr. 2000. PMID: 11113835 Clinical Trial.

3

Celiac disease presenting with chilblains in an adolescent girl.

St Clair NE, Kim CC, Semrin G, Woodward AL, Liang MG, Glickman JN, Leichtner AM, Binstadt BA. St Clair NE, et al. Among authors: leichtner am. Pediatr Dermatol. 2006 Sep-Oct;23(5):451-4. doi: 10.1111/j.1525-1470.2006.00281.x. Pediatr Dermatol. 2006. PMID: 17014640

4

Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.

Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Zholudev A, et al. Am J Gastroenterol. 2004 Nov;99(11):2235-41. doi: 10.1111/j.1572-0241.2004.40369.x. Am J Gastroenterol. 2004. PMID: 15555007

5

Serum leptin in children and young adults with inflammatory bowel disease.

Hoppin AG, Kaplan LM, Zurakowski D, Leichtner AM, Bousvaros A. Hoppin AG, et al. Among authors: leichtner am. J Pediatr Gastroenterol Nutr. 1998 May;26(5):500-5. doi: 10.1097/00005176-199805000-00003. J Pediatr Gastroenterol Nutr. 1998. PMID: 9586759

6

Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity.

Bousvaros A, Zurakowski D, Duggan C, Law T, Rifai N, Goldberg NE, Leichtner AM. Bousvaros A, et al. Among authors: leichtner am. J Pediatr Gastroenterol Nutr. 1998 Feb;26(2):129-35. doi: 10.1097/00005176-199802000-00002. J Pediatr Gastroenterol Nutr. 1998. PMID: 9481625

7

Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.

Bross DA, Leichtner AM, Zurakowski D, Law T, Bousvaros A. Bross DA, et al. Among authors: leichtner am. J Pediatr Gastroenterol Nutr. 1996 Aug;23(2):164-71. doi: 10.1097/00005176-199608000-00012. J Pediatr Gastroenterol Nutr. 1996. PMID: 8856584 Clinical Trial.

8

Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease.

Bousvaros A, Leichtner A, Zurakowski D, Kwon J, Law T, Keough K, Fishman S. Bousvaros A, et al. Dig Dis Sci. 1999 Feb;44(2):424-30. doi: 10.1023/a:1026635308127. Dig Dis Sci. 1999. PMID: 10063933

9

Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease.

Srivastava M, Zurakowski D, Cheifetz P, Leichtner A, Bousvaros A. Srivastava M, et al. J Pediatr Gastroenterol Nutr. 2001 Nov;33(5):548-53. doi: 10.1097/00005176-200111000-00007. J Pediatr Gastroenterol Nutr. 2001. PMID: 11740227

10

Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing.

Bousvaros A, Zurakowski D, Fishman SJ, Keough K, Law T, Sun C, Leichtner AM. Bousvaros A, et al. Among authors: leichtner am. Dig Dis Sci. 1997 Feb;42(2):378-86. doi: 10.1023/a:1018882322566. Dig Dis Sci. 1997. PMID: 9052523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page